Holen Sie sich die Stockscreener-App
18.03
4.34%
0.75
Schlusskurs vom Vortag:
$17.28
Offen:
$17.63
24-Stunden-Volumen:
708.89K
Relative Volume:
2.39
Marktkapitalisierung:
$684.11M
Einnahmen:
$95.07M
Nettoeinkommen (Verlust:
$-60.37M
KGV:
-11.07
EPS:
-1.6291
Netto-Cashflow:
$-50.92M
1W Leistung:
-0.66%
1M Leistung:
+8.75%
6M Leistung:
-15.55%
1J Leistung:
+1.29%
1-Tages-Spanne:
$17.45
$18.08
1-Wochen-Bereich:
$17.07
$18.80
52-Wochen-Spanne:
$10.85
$24.33
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
18.03 | 684.11M | 95.07M | -60.37M | -50.92M | -1.6291 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
CeriBell Inc (CBLL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CeriBell Inc (CBLL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CeriBell Inc (CBLL) Valuation: PE, PB & Fair Value Analysis - TradingKey
CeriBell Inc (CBLL) Institutional Confidence - TradingKey
CeriBell Inc (CBLL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CeriBell Inc (CBLL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CeriBell Inc (CBLL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CeriBell Inc (CBLL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CeriBell Inc (CBLL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ceribell, Inc. identifies hidden seizure in child using rapid EEG in emergency room - Traders Union
Insider Sell Alert: Joseph Taylor Sells 5,500 Shares of CeriBell Inc (CBLL) - GuruFocus
High-Profile Insider Move Shakes Up Investor Buzz at Ceribell, Inc. - TipRanks
Ceribell director Joseph Taylor sells $101,255 in common stock By Investing.com - Investing.com South Africa
Ceribell director Joseph Taylor sells $101,255 in common stock - Investing.com
Ceribell | 4: Statement of changes in beneficial ownership of securities-Director Taylor Joseph Michael - Moomoo
CeriBell Inc. (CBLL) Q1 2026 Earnings: EPS Miss of 30.7% Highlights Rising Costs, No Revenue ReportedForward Guidance Trends - newsline.com
Ceribell, Inc. launches FDA-cleared device for bedside diagnosis and delirium monitoring - Traders Union
CBLL Q1 2026 Earnings: EPS Misses Estimates, Stock Shows ResilienceEarnings Outlook Update - newsline.com
Ceribell Insider Sold Shares Worth $714,870, According to a Recent SEC Filing - Moomoo
CBLL Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares DeclinePre-Earnings Drift - newsline.com
Ceribell CEO Chao sells $714,870 in common stock By Investing.com - Investing.com Nigeria
Ceribell CEO Chao sells $714,870 in common stock - Investing.com
CeriBell Inc. (CBLL) Shows Strength with 4% Gain: Technical Levels and Market ContextIsland Reversal - newsline.com
FDA-approved ceribell EEG shortens seizure diagnosis by monitoring brain activity - CBS News
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes - The Manila Times
AI EEG tool links ICU seizure burden to death and disability risk - Stock Titan
CBLL Q1 2026 Earnings: Wider-than-Expected Loss Disappoints InvestorsSlow Growth Warning - newsline.com
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
William Blair Maintains Ceribell(CBLL.US) With Buy Rating - Moomoo
Ceribell Announces Director Elections at 2026 Annual Meeting - The Globe and Mail
CBLL Technical Analysis | Trend, Signals & Chart Patterns | CERIBELL INC (NASDAQ:CBLL) - ChartMill
InvestingPro’s Fair Value warned of CeriBell crash 17 months ago By Investing.com - Investing.com
CeriBell Inc. (CBLL) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Per Share - newsline.com
Ceribell Leadership Unloads Shares in a Wave of Insider Stock Moves - TipRanks
CeriBell (CBLL) Holds Near Support Amid Modest GainsFibonacci Fan - newsline.com
EEG adoption accelerates in urgent seizure detection, Ceribell, Inc. pushes - Traders Union
CeriBell Inc. (CBLL) Q1 2026 Earnings: EPS Misses Estimates by 30.7%, Stock Edges HigherFull Year Guidance - newsline.com
Ceribell CEO to present at William Blair Growth Stock Conference on June 3, 2026 - Pluang
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference - Moomoo
Earnings call transcript: Ceribell Inc. Q1 2026 misses EPS, revenue up - Investing.com Nigeria
Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL) - The Globe and Mail
Canaccord Genuity maintains Ceribell (CBLL) buy recommendation - MSN
Ceribell anticipates $112M-$116M 2026 revenue while targeting delirium NTAP of up to $2,171 per patient - MSN
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records - Yahoo Finance
Ladenburg Thalmann Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins - TipRanks
Ceribell’s Earnings Call Signals Growth Over Profits - The Globe and Mail
TD Cowen Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $29 - Moomoo
A Quick Look at Today's Ratings for Ceribell(CBLL.US), With a Forecast Between $25 to $29 - Moomoo
Canaccord lowers Ceribell stock price target on valuation compression By Investing.com - Investing.com Australia
Canaccord lowers Ceribell stock price target on valuation compression - Investing.com
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):